Oculogica Publishes 5-Site Study on Its FDA-Cleared Concussion Diagnostic
Oculogica's EyeBOX
NEW YORK, February 6, 2023 (Newswire.com)
–
Oculogica Inc. announces publication of the initial five-site study performed to obtain FDA Marketing Authorization for its EyeBOX tech…